Ellen Pierre de Oliveira

Ellen Pierre de Oliveira

Auto-generated profile, based on publicly available information

Ellen Pierre de Oliveira

Adult-ICU Albert Einstein Hospital, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
RMRenata Aparecida de Almeida Monteiro
Renata Aparecida de Almeida Monteiro
ADAmaro Duarte-Neto
Amaro Duarte-Neto
LSLuiz Fernando Ferraz da Silva
Luiz Fernando Ferraz da Silva
EOEllen Pierre de Oliveira
Ellen Pierre de Oliveira
JFJAIR THEODORO FILHO
JAIR THEODORO FILHO
MDMarisa Dolhnikoff
Marisa Dolhnikoff
INTRODUCTION Over the last few decades, there has been a dramatic decrease in the number of hospital autopsies conducted around the world. However, autopsies are important for increasing our understanding of novel diseases. For example, autopsies were of vital importance in understanding acquired immunodeficiency syndrome (AIDS) and H1N1. There is a lack of literature on autopsies conducted on patients that have died of COVID-19 despite the high number of deaths worldwide. This is probably due to the risk of contagion, [...] INTRODUCTION Over the last few decades, there has been a dramatic decrease in the number of hospital autopsies conducted around the world. However, autopsies are important for increasing our understanding of novel diseases. For example, autopsies were of vital importance in understanding acquired immunodeficiency syndrome (AIDS) and H1N1. There is a lack of literature on autopsies conducted on patients that have died of COVID-19 despite the high number of deaths worldwide. This is probably due to the risk of contagion,

1 June 2020 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
EOEllen Pierre de Oliveira
Ellen Pierre de Oliveira
PJPedro Medeiros Junior
Pedro Medeiros Junior
Palliative care was initially developed for patients with advanced cancer. The concept has evolved and now encompasses any life-threatening chronic disease. Studies carried out to compare end-of-life symptoms have shown that although symptoms such as pain and dyspnea are as prevalent in patients with lung disease as in patients with cancer, the former receive less palliative treatment than do the latter. There is a need to refute the idea that palliative care should be adopted only when curative treatment is no longer possible. Palliative care should be provided in conjunction with curative treatment at the time of diagnosis, by means of a joint decision-making process; that is, the patient and the physician should work together to plan the therapy, seeking to improve quality of life while reducing physical, psychological, and spiritual suffering.

1 January 2019 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
WSWilliam Salibe-Filho
William Salibe-Filho
BPBruna Mamprim Piloto
Bruna Mamprim Piloto
EOEllen Pierre de Oliveira
Ellen Pierre de Oliveira
MCMarcela Araújo Castro
Marcela Araújo Castro
BABreno Boueri Affonso
Breno Boueri Affonso
MTMário Terra-Filho
Mário Terra-Filho
Objective: To present a case series of pulmonary arteriovenous malformations (PAVMs), describing the main clinical findings, the number/location of pulmonary vascular abnormalities, the clinical complications, and the treatment administered. Methods: This was a retrospective observational study evaluating patients with PAVM divided into two groups: hereditary hemorrhagic telangiectasia (HHT); and idiopathic PAVM (iPAVM). Results: A total of 41 patients were selected for inclusion, but only 33 had PAVMs. After clinical evaluation, 27 and 6 were diagnosed with HHT and iPAVM, respectively. In the HHT group, the mean age was 49.6 years and 88.9% were female. In that group, 4 patients had an SpO2 of < 90% and the most common clinical finding was epistaxis. In the iPAVM group, the mean age was 48.1 years and 83.3% were female. In that group, 3 patients had an SpO2 of < 90%. Computed tomographic pulmonary angiography showed that most of the PAVMs were in the lower lobes: 56.4% in the HHT group and 85.7% in the iPAVM group. Embolization was performed in 23 patients (in both groups). At this writing, 10 patients are scheduled to undergo the procedure. One of the patients who underwent embolization was subsequently referred for pulmonary resection. Conclusions: In both of the PAVM groups, there was a predominance of women and of fistulas located in the lower lobes. Few of the patients had respiratory symptoms, and most had an SpO2 > 90%. The treatment chosen for all patients was percutaneous transcatheter embolization.

1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
CFCaio Julio Cesar dos Santos Fernandes
Caio Julio Cesar dos Santos Fernandes
EOEllen Pierre de Oliveira
Ellen Pierre de Oliveira
WSWillian Salibe-Filho
Willian Salibe-Filho
MTMario Terra-Filho
Mario Terra-Filho
CJCarlos Vianna Poyares Jardim
Carlos Vianna Poyares Jardim
RSRogerio de Souza
Rogerio de Souza
Chronic thromboembolic pulmonary hypertension (CTEPH) is a unique form of pulmonary hypertension (PH) that arises from obstruction of the pulmonary vessels by recanalized thromboembolic material. CTEPH has a wide range of radiologic presentations. Commonly, it presents as main pulmonary artery enlargement, peripheral vascular obstructions, bronchial artery dilations, and mosaic attenuation patterns. Nevertheless, other uncommon presentations have been described, such as lung cavities. These lesions may be solely related to chronic lung parenchyma ischemia but may also be a consequence of concomitant chronic infectious conditions. The objective of this study was to evaluate the different etiologies that cause lung cavities in CTEPH patients. A retrospective data analysis of the medical records of CTEPH patients in a single reference PH center that contained or mentioned lung cavities was conducted between 2013 and 2016. Seven CTEPH patients with lung cavities were identified. The cavities had different sizes, locations, and wall thicknesses. In two patients, the cavities were attributed to pulmonary infarction; in 5 patients, an infectious etiology was identified. Despite the possibility of being solely associated with chronic lung parenchyma ischemia, most cases of lung cavities in CTEPH patients were associated with chronic granulomatous diseases, reinforcing the need for active investigation of infectious agents in this setting.

1 March 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
TBTiago Spiazzi Bottega
Tiago Spiazzi Bottega
MVMarcele Gnata Vier
Marcele Gnata Vier
HBHugo Baldiaserotto
Hugo Baldiaserotto
EOEllen Pierre de Oliveira
Ellen Pierre de Oliveira
CDClaudia Liliana Moreno Diaz
Claudia Liliana Moreno Diaz
CFCaio J. Fernandes
Caio J. Fernandes
SUMMARY OBJECTIVES Acute pulmonary embolism (APE) is an important cause of cardiovascular mortality, due mainly to hemodynamic instability. In these cases, the recommendation is to perform some reperfusion procedure, with systemic thrombolysis being the main therapy used. However, national data evaluating the efficacy and safety of thrombolysis are scarce. METHODS Retrospective analysis of a case series. We included 13 patients diagnosed with high-risk APE and 4 patients with intermediate-high risk from a single-center, who were treated with alteplase 100mg. RESULTS The mean age of the patients was 55 years, most of them female (76.4%). Among the risk factors for VTE were immobilization (41.17%), contraceptive use (35.29%), cancer (17.63%), and previous history of DVT (11.76%). The most frequent clinical manifestations of APE were dyspnea (88.23%), hypoxia (82.35%), hypotension (82.35%), and tachycardia (64.70%). 82.35% of the patients had echocardiographic signs of right ventricular dysfunction, and 52.94% had increased troponin and BNP. Severe bleeding associated with thrombolysis occurred in 17.54% of cases. No patient died due to bleeding. There were 8 deaths from right ventricular failure (47%), 6 in the cases of patients presenting as high-risk APE (35.3%), and 2 in the cases of intermediate-high risk (11.8%). CONCLUSION Thrombolysis in patients with high-risk APE or intermediate-high risk had a severe bleeding rate of 17.6%. However, the high mortality of this population (47%) due to right ventricular failure justifies the use of this therapeutic modality.

1 January 2022 in Medical Research Archives
Verified
Journal Article
Open access
PDF file
EOEllen Pierre Oliveira
Ellen Pierre Oliveira
GAGabriela Lins Medeiros Assunção
Gabriela Lins Medeiros Assunção
MTMarcos Soares Tavares
Marcos Soares Tavares
CCCarlos Roberto Ribeiro Carvalho
Carlos Roberto Ribeiro Carvalho
CBCarmen Silvia Valente Barbas
Carmen Silvia Valente Barbas
Hookah originates from India and in the last years spread around the world. The culture and the mystique behind this device promoted the use among the young population. Despite the thought that is the new safe way to smoke tobacco, recent studies showed that it can be more harmful than the cigarette, becoming a public health problem. Hookah increases airway reactivity and inflammation, causing an inflammation in the respiratory and cardiovascular system. The inhaled smoke contains chemicals agents that are toxic to the lung. As known in the literature the inhaled substance can lead to an acute eosinophilic pneumonia with a pulmonary interstitial infiltrate on radiological image. The degree of pulmonary involvement is varied and may cause a serious condition, requiring hospital admission and intensive care support. The treatment consists of ceasing the hookah use and the use of systemic corticosteroids. One important damage to the health is the infection disease like the tuberculosis transmission, cause by sharing the devise. In the cardiovascular system, the alterations were increasing the cardiac frequency and blood pressure in addition to causing inflammation in the endothelium of the vessel. Long-term studies are needed to correlate the use of this device with the risk of developing cancer.